Release Date: 08/05/19 08:56 Summary: CSR Limited Review of Results -full year ended 31 March 2019 Price Sensitive: Yes Download Document 172.97KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution